Concepedia

Jisong Li

JL

3

Publications

78

Citations

3

H-Index

1992

Active since

Affiliations

Peking University(Current)

Capital Medical University

Beijing Shijitan Hospital

Peking University First Hospital

Jisong Li is an author at Peking University specializing in medicinal chemistry, transcriptional regulation, and natural sciences.

ORCID

Top concepts

Publications per year

1992–2022

3

Publications

3

BRM transcriptionally regulates miR-302a-3p to target SOCS5/STAT3 signaling axis to potentiate pancreatic cancer metastasis

Zhengkui Zhang, Jisong Li, Huahu Guo et al. · Cancer Letters · 2019 · 32 citations

, , +8

4-pregnene-3-one-20β-carboxaldehyde: A potent inhibitor of 17α-hydroxylase/C17,20-lyase and of 5α-reductase

Jisong Li, Yan Li, Chong Son et al. · The Journal of Steroid Biochemistry and Molecular Biology · 1992 · 27 citations

, , +2

Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1

Mingzhe Li, Jiaxin Zhou, Zhengkui Zhang et al. · Chinese Medical Journal · 2022 · 19 citations · Full text

Rows per page

1–3 of 3